Evaluating tamoxifen effect in the prevention of hypertrophic scars following surgical incisions

Dermatologic Surgery

Volumn 36, Issue 5, 2010, Pages 665-669

  Mousavi, Seyed Reza ^a   Raaiszadeh, Mohamad ^a   Aminseresht, Mohamad ^a   Behjoo, Shahin ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; TAMOXIFEN;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FLUSHING; HUMAN; HYPERTROPHIC SCAR; MAJOR CLINICAL STUDY; MALE; NAUSEA; POSTOPERATIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SKIN INCISION; SKIN SURGERY; URINE RETENTION;

ADMINISTRATION, ORAL; CICATRIX, HYPERTROPHIC; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ESTROGEN ANTAGONISTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SKIN; TAMOXIFEN; TREATMENT OUTCOME; WOUND HEALING;

EID: 77951261196     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2010.01526.x     Document Type: Article

References (20)

1. Joanna M. Zurodu: topical treatment of hypertrophic scar. J Am Acad Dermatol 2006 55 : 1024 1031.
2. Leivis SK. Hypertrophic scar: a genetic hypothesis. Burn's 1990 16 : 176 179.
3. Niessen FB, Spauwen PH, Schalkwijk J, Kon M. On the nature of hypertrophic scar and keloid. Plast Reconstr Surg 1999 104 : 1435 1438.
4. Brody GS, Peng ST, Landel RF. The etiology of hypertrophic scar contracture. Plast Reconstr Surg 1981 67 : 637 684.
5. Iannellos, et al. Low dose enalapril in the treatment of surgical cutaneous hypertrophic scar and keloid-two case report and literature review. Med Gen Med 2006 8 : 6.
6. Leventhal D, Furr M, Reiter D. Treatment of keloid and hypertrophic scar: a meta-analysis and literature review. Arch Facial Plast Surg 2006 8 : 362 368.
7. Grainger DJ, Weissberg PL, Metcalfe JC. Tamoxifen decreases the rate of proliferation of rat vascular smooth-muscle cells in culture by inducing production of transforming growth factor beta. Biochem J 1993 294 (Pt 1) : 109 112.
8. Hu D, Hughes MA, Cherry GW. Topical tamoxifen a potential therapeutic regimen in treating excessive dermal scarring? Br J Plast Surg 1998 51 : 462 469.
9. Mikulec AA, Hanasono MM, Lum J, et al. Effect of tamoxifen on transforming growth factor beta 1 production by keloid and fetal fibroblasts. Arch Facial Plast Surg 2001 3 : 111 114.
10. Hu D, Zhu X, Xu M, et al. The inhibitory effect of tamoxifen on human dermal fibroblast populated collagen lattices. Zhonghua Zheng Xing Wai Ke Za Zhi 2002 18 : 160 162.
11. del Peso G, Bajo MA, Gil F, et al. Clinical experience with tamoxifen in peritoneal fibrosing syndromes. Adv Perit Dial 2003 19 : 32 5.
12. Tan M, Uygur MC, Diker Y, Erol D. Remission of idiopathic retroperitoneal fibrosis after sequential therapy with corticosteroids and tamoxifen. Urol Int 2003 71 : 426 429.
13. Ruffy MB, Iannello S, Milazzo P, et al. Effect of tamoxifen on normal human dermal fibroblast. Arch Facial Plast Surg 2006 8 : 329 332.
14. Chrousos G, Zoumakix E, Gravanis A. The gonadal hormones & inhibitors. Mol Hum Reprod 1999 5 : 789 796.
15. Maarouf M, Schleicher U, Schmachtenberg A, Ammon J. Radiotherapy in the management of keloids. Clinical experience with electron beam irradiation and comparison with X-ray therapy. Strahlenther Onkol 2002 178 : 330 335.
16. Marneros AG, Norris JE, Watanabe S, et al. Genome scans provide evidence for keloid susceptibility loci on chromosomes 2q23 and 7p11. J Invest Dermatol 2004 122 : 1126 1132.
17. Botwood N, Lewanski C, Lowdell C. The risks of treating keloids with radiotherapy. Br J Radiol 1999 72 : 1222 1224.
18. Dinh Q, Veness M, Richards S. Role of adjuvant radiotherapy in recurrent earlobe keloids. Australas J Dermatol 2004 45 : 162 166.
19. Ragoowansi R, Cornes PG, Moss AL, Glees JP. Treatment of keloids by surgical excision and immediate postoperative single-fraction radiotherapy. Plast Reconstr Surg 2003 111 : 1853 1859.
20. Kuhn MA, Wang X, Payne WG, Ko F, Robson MC. Tamoxifen decreases fibroblast function and downregulates TGF(beta2) in Dupuytren's affected palmar fascia. J Surg Res 2002 103 : 146 152.